AEGIR — Aegirbio AB Cashflow Statement
0.000.00%
- SEK14.76m
- SEK51.57m
- SEK0.09m
Annual cashflow statement for Aegirbio AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 11 W | 10 W | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0 | -10.3 | -80.2 | -365 | -56.2 |
Depreciation | |||||
Non-Cash Items | — | -0.029 | — | 303 | -2.21 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0 | 2.94 | -37.2 | 0.384 | -0.089 |
Change in Accounts Receivable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0 | -7.41 | -109 | -49 | -41.9 |
Capital Expenditures | 0 | -0.098 | 0 | -0.065 | -5.54 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | 1.6 | 0 | — |
Sale of Business | |||||
Cash from Investing Activities | 0 | -0.098 | 1.6 | -0.065 | -5.54 |
Financing Cash Flow Items | — | — | — | -9.25 | -3.9 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | 0.23 | 131 | 29.3 | 45 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0 | -7.27 | 23.6 | -19.4 | -2.45 |